| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.32 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |